Treatment with elexacaftor/tezacaftor/ivacaftor does not alter SpiroNose-derived electronic breath profiles in children with cystic fibrosis

Journal of Cystic Fibrosis · Elsevier

The publisher did not provide an abstract — full text is available via the link below.

Read at publisher →

Similar articles